Home> Products> careful adjustment

{ "products": [ { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891b0287b16001ae8bc9da2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CITICOTIME PM", "description": "CITICOTIME PM is a specialized formulation combining Citicoline 500mg and Piracetam 800mg in tablet form, designed to enhance brain health and cognitive functions. This combination harnesses the synergistic effects of two well-researched nootropic agents—citicoline and piracetam tablets—widely used in neurological therapies. Primarily, this medicine supports nerve cell nourishment, protects neurons from damage, and aids in improving memory, focus, and recovery in brain-related conditions such as stroke. Its unique formulation offers neuroprotection and cognitive enhancement, making it an important therapeutic option in treating stroke and other cognitive impairments.\n\nWhat is CITICOTIME PM?\nCITICOTIME PM contains a combination of two active ingredients: Citicoline 500mg, a neuroprotective compound that promotes brain cell repair and function, and Piracetam 800mg, which enhances neuronal communication and cognitive processes. Together, they work to support brain metabolism, improve blood flow, and strengthen cognitive resilience. This formulation is often prescribed to patients recovering from neurological injuries or those experiencing cognitive decline.\n\nUses of Citicoline and Piracetam Tablets\n\nTreatment and recovery support in stroke patients to restore brain function\n\nImprovement of memory, learning ability, and cognitive performance\n\nManagement of neurological disorders such as dementia and Alzheimer's disease\n\nNeuroprotection against brain cell damage caused by trauma or ischemia\n\nEnhancement of mental alertness and reduction of cognitive fatigue\n\nSupport in conditions involving cognitive impairment due to aging or injury\n\nCiticoline + Piracetam is used in the treatment of stroke. Citicoline + Piracetam is a combination of two medicines: Citicoline and Piracetam. Citicoline is a nerve protecting medicine. It works on the brain by nourishing the nerve cells, protects them from damage and improves their survival.\n\nCiticoline and Piracetam Tablets Dosage\nThe recommended dosage depends on the patient's condition, age, and response to therapy. Typically, CITICOTIME PM is taken once or twice daily as prescribed by a healthcare professional. Each tablet delivers Citicoline 500mg and Piracetam 800mg, providing an effective dose for neuroprotection and cognitive support. It should be swallowed whole with water, preferably after meals to reduce gastrointestinal discomfort. Dosage adjustments may be necessary in patients with kidney impairment or other comorbidities. It is critical to follow a doctor's prescribed dosage and not to self-medicate.\n\nSide Effects of Citicoline and Piracetam Tablets\nWhile generally well tolerated, some individuals may experience side effects, which are usually mild and temporary, including:\n\nHeadache\n\nNausea and stomach discomfort\n\nInsomnia or trouble sleeping\n\nNervousness or agitation\n\nDizziness and vertigo\n\nWeight gain in some cases\n\nRare allergic reactions such as skin rash or swelling\n\nChanges in blood pressure or heart rate (typically uncommon)\n\nIf severe side effects or allergic reactions occur, immediate medical attention is advised.\n\nPrecautions Before Using CITICOTIME PM\n\nConsult a doctor before use if you have a history of brain hemorrhage, bleeding disorders, or gastrointestinal ulcers.\n\nUse caution in elderly patients and those with renal or hepatic impairment.\n\nAvoid driving or operating heavy machinery until you know how the medicine affects you.\n\nDo not consume alcohol while taking this medication, as it may increase side effects like drowsiness or nervousness.\n\nInform your healthcare provider if you are pregnant, trying to conceive, or breastfeeding, as safety in these conditions is not fully established.\n\nDo not abruptly stop the medication without medical advice to avoid withdrawal symptoms such as muscle twitching.\n\nDrug Interactions: What Drugs Interact with CITICOTIME PM?\n\nAnticoagulants or blood thinners may increase the risk of bleeding.\n\nOther central nervous system (CNS) stimulants or depressants can enhance side effects like dizziness or drowsiness.\n\nMedications processed by kidneys require careful monitoring as both citicoline and piracetam are primarily excreted renally.\n\nAlcohol consumption can exacerbate side effects, especially sedation and nervousness.\n\nAlways inform your doctor about all medications and supplements you are taking to avoid harmful interactions.\n\nCITICOTIME PM, with citicoline 500mg and piracetam 800mg, is a reliable choice for managing stroke recovery and cognitive disorders by protecting and nourishing nerve cells, improving brain function, and supporting neuronal survival. Proper medical supervision is essential to maximize benefits and minimize risks associated with citicoline and piracetam tablets uses and dosage.", "price": 529.0, "discountamount": 159.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2155, "imageuri": "https://productimages.withfloats.com/actual/6891b02f5058847bfcd48899.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891b02f5058847bfcd48899.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T07:18:00.92Z", "updatedon": "2025-08-05T07:18:00.92Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/citicotime-pm/2155", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "citicoline and piracetam tablets", "category": "NEUROLOGY RANGE", "tags": [ "citicoline and piracetam tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ac1c8d0d0330684bdbc69", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 4 ", "description": "NICOMALOM 4 \nNicoumalone (4mg)\nIntroduction:\n\nNICOMALOM 4 contains Nicoumalone (4 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 4 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 4 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-4-133593", "price": 389.4, "discountamount": 116.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "4 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1862, "imageuri": "https://productimages.withfloats.com/actual/667d22cdba7e6420d2a5125f.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d22cdba7e6420d2a5125f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:54:16.529Z", "updatedon": "2024-06-27T08:29:00.414Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-4-/1862", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 4 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 4 mg tablet price", "nicoumalone 4mg", "nicoumalone 1mg uses in hindi", "acitrom 4mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abf93396cee0250f91bbf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 3 ", "description": "NICOMALOM 3 \nNicoumalone (3mg)\nIntroduction:\n\nNICOMALOM 3 contains Nicoumalone (3 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 3 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 3 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-3-133592", "price": 359.4, "discountamount": 107.82, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "EMAIL", "water", "Doses", "heart", "tablet", "product", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "3 mg dosage", "information", "INR) levels", "Nicoumalone", "initial dose", "sterisonline", "Key Features", "sterispharma", "Introduction", "CALL/WHATSAPP", "long-term use", "Initial Dosage", "Administration", "prothrombin time", "most indications", "target INR range", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1861, "imageuri": "https://productimages.withfloats.com/actual/666abf968b71a2cb2d7d4e2d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666abf968b71a2cb2d7d4e2d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:44:51.78Z", "updatedon": "2024-06-26T11:15:50.58Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-3-/1861", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 3 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 3mg uses", "nicoumalone side effects", "nicoumalone tablet uses in hindi", "nicoumalone contraindications", "nicoumalone tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abe06cee93a1bbc383645", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 2 ", "description": "NICOMALOM 2 \nNicoumalone (2mg)\nIntroduction:\n\nNICOMALOM 2 contains Nicoumalone (2 mg), a potent anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 2 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 2 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/nicomalom-2-133591", "price": 243.0, "discountamount": 72.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "heart", "water", "Doses", "EMAIL", "tablet", "patients", "Benefits", "NICOMALOM", "synthesis", "same time", "Nicoumalone", "2 mg dosage", "INR) levels", "information", "Introduction", "Key Features", "sterisonline", "initial dose", "sterispharma", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "target INR range", "prothrombin time", "most indications", "maintenance dose", "affordable option", "careful monitoring", "Maintenance Dosage", "chronic conditions", "pulmonary embolism", "healthcare provider", "regular blood tests", "atrial fibrillation", "Standardized Dosing", "precise adjustments", "deep vein thrombosis", "blood clot formation", "Long-Term Management", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "consistent blood levels", "optimal anticoagulation", "thromboembolic disorders", "Thromboembolism Prevention", "International Normalized Ratio", "potent anticoagulant medication", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1860, "imageuri": "https://productimages.withfloats.com/actual/666abe098b71a2cb2d7d3c68.png", "tileimageuri": "https://productimages.withfloats.com/tile/666abe098b71a2cb2d7d3c68.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:38:14.673Z", "updatedon": "2024-06-26T11:13:41.928Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-2-/1860", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 2 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone 2mg uses", "nicoumalone tablet", "nicoumalone tablets side effects", "nicoumalone tablet dosage", "nicoumalone drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666abcb0f7438b1754ba0c31", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NICOMALOM 1 ", "description": "NICOMALOM 1 \nNicoumalone (1mg)\nIntroduction:\n\nNICOMALOM 1 contains Nicoumalone (1 mg), an anticoagulant medication used to prevent and treat thromboembolic disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke in patients with atrial fibrillation. Nicoumalone works by inhibiting the synthesis of vitamin K-dependent clotting factors, thereby reducing blood clot formation.\nKey Features and Benefits:\n\nThromboembolism Prevention: Nicoumalone effectively reduces the risk of blood clot formation, helping to prevent conditions like DVT and PE.\nStroke Risk Reduction: It is beneficial for patients with atrial fibrillation, reducing the risk of stroke by preventing clot formation in the heart.\nLong-Term Management: Nicoumalone is suitable for long-term use in patients with chronic conditions that predispose them to thromboembolic events.\nStandardized Dosing: The 1 mg dosage allows for precise adjustments based on the patient's prothrombin time (PT) and International Normalized Ratio (INR) levels, ensuring optimal anticoagulation.\nCost-Effective: As an established anticoagulant, Nicoumalone offers an affordable option for long-term management of thromboembolic disorders.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of NICOMALOM 1 is determined based on the patient's INR, with adjustments made according to regular blood tests. The initial dose may vary, but careful monitoring is essential.\nMaintenance Dosage: The maintenance dose is individualized based on the target INR range, usually between 2.0 and 3.0 for most indications. Doses are adjusted by a healthcare provider based on regular INR monitoring.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Nicoumalone at the same time each day to maintain consistent blood levels.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/nicomalom-1-133590", "price": 183.0, "discountamount": 54.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "DVT", "food", "Doses", "heart", "EMAIL", "water", "tablet", "product", "Benefits", "patients", "NICOMALOM", "same time", "synthesis", "Nicoumalone", "INR) levels", "1 mg dosage", "information", "Introduction", "initial dose", "sterispharma", "Key Features", "sterisonline", "long-term use", "CALL/WHATSAPP", "Administration", "Initial Dosage", "most indications", "target INR range", "prothrombin time", "maintenance dose", "affordable option", "Maintenance Dosage", "careful monitoring", "chronic conditions", "pulmonary embolism", "healthcare provider", "atrial fibrillation", "regular blood tests", "Standardized Dosing", "precise adjustments", "Long-Term Management", "deep vein thrombosis", "blood clot formation", "thromboembolic events", "Stroke Risk Reduction", "typical starting dose", "regular INR monitoring", "optimal anticoagulation", "consistent blood levels", "thromboembolic disorders", "anticoagulant medication", "Thromboembolism Prevention", "International Normalized Ratio", "vitamin K-dependent clotting factors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1859, "imageuri": "https://productimages.withfloats.com/actual/666abcb4f068be46bdeaf907.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666abcb4f068be46bdeaf907.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T09:32:32.095Z", "updatedon": "2024-06-26T11:06:41.45Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nicomalom-1-/1859", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NICOMALOM 1 ", "category": "NEUROLOGYRANGE", "tags": [ "nicoumalone tablet 1mg", "nicoumalone 1mg uses in hindi", "nicoumalone 1mg price", "", "nicoumalone class of drug", "acenocoumarol drug interactions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6666cbdf3b4bb82214047a09", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HYCHLORZIDE 12.5", "description": "HYCHLORZIDE 12.5\nHydrochlorothiazide (12.5mg)\nHychlorzide 12.5, containing Hydrochlorothiazide (12.5mg), is a diuretic medication used to treat high blood pressure (hypertension) and fluid retention (edema) in conditions such as congestive heart failure, kidney disorders, and liver cirrhosis. Here are key points about Hychlorzide 12.5:\n\nMedication Class: Hychlorzide 12.5 belongs to the thiazide diuretic class, helping the body eliminate excess salt and water, reducing fluid buildup.\n\nBlood Pressure Management: It works by increasing urine production, which helps lower blood pressure. This can reduce the risk of strokes, heart attacks, and kidney problems.\n\nFluid Retention: Hychlorzide 12.5 is effective in treating edema by removing excess fluid from the body, relieving swelling in the feet, ankles, and legs.\n\nDosage: The typical dose for adults is 12.5mg once daily, usually in the morning. Dosage adjustments may be necessary based on individual response and medical condition.\n\nAdministration: It can be taken with or without food, but consistent timing is important for best results. Follow your healthcare provider's instructions carefully.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/hychlorzide-12-5-133488", "price": 10.0, "discountamount": 3.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "Call", "feet", "body", "food", "legs", "edema", "Email", "water", "ankles", "12.5mg", "adults", "strokes", "morning", "swelling", "WhatsApp", "conditions", "key points", "excess salt", "information", "HYCHLORZIDE", "instructions", "sterispharma", "hypertension", "sterisonline", "best results", "typical dose", "excess fluid", "heart attacks", "fluid buildup", "Administration", "liver cirrhosis", "kidney problems", "fluid retention", "Medication Class", "urine production", "kidney disorders", "consistent timing", "medical condition", "Dosage adjustments", "individual response", "healthcare provider", "diuretic medication", "high blood pressure", "Hydrochlorothiazide", "thiazide diuretic class", "congestive heart failure", "Blood Pressure Management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1656, "imageuri": "https://productimages.withfloats.com/actual/6666cbe2c9162f54a1505e23.png", "tileimageuri": "https://productimages.withfloats.com/tile/6666cbe2c9162f54a1505e23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T09:48:15.145Z", "updatedon": "2024-06-29T10:16:16.077Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/hychlorzide-12-5/1656", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "HYCHLORZIDE 12.5", "category": "UROLOGYRANGE", "tags": [ "HYCHLORZIDE 12.5 mg", "Hydrochlorothiazide (12.5mg)", "HYCHLORZIDE 12.5 mg uses", "HYCHLORZIDE 12.5 dosage", "HYCHLORZIDE 12.5 mg side effects", "HYCHLORZIDE 12.5 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661af452bed1f08484d625b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIGLICLAGLAZE 30 ", "description": "TRIGLICLAGLAZE 30 \nGliclazide (SR) Pioglitazone and Metformin HCL (SR)\nTRIGLICLAGLAZE 30 is a combination medication formulated to manage type 2 diabetes mellitus effectively. It combines three key components: Gliclazide (SR), Pioglitazone, and Metformin HCI (SR), each targeting different aspects of glucose regulation to achieve optimal blood sugar control.\n\nGliclazide (SR): Gliclazide is a sulfonylurea medication that works by stimulating the pancreas to release insulin, which helps lower blood sugar levels. The sustained-release (SR) formulation ensures a gradual and prolonged release of the medication, providing consistent glucose-lowering effects throughout the day.\n\nPioglitazone: Pioglitazone belongs to the thiazolidinedione class of drugs and enhances insulin sensitivity in muscle and fat tissues. By improving the body's response to insulin, Pioglitazone helps reduce insulin resistance and promotes better glucose utilization by cells.\n\nMetformin HCI (SR): Metformin is a biguanide medication that works primarily by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues. The sustained-release formulation ensures a gradual release of Metformin, minimizing gastrointestinal side effects and providing extended blood sugar control.\n\nKey Benefits of TRIGLICLAGLAZE 30:\nComprehensive Glucose Control: The combination of Gliclazide (SR), Pioglitazone, and Metformin HCI (SR) targets multiple pathways involved in glucose metabolism. This comprehensive approach helps achieve better overall blood sugar control throughout the day.\n\nStimulates Insulin Release: Gliclazide stimulates insulin secretion from the pancreas, especially after meals, which is crucial for managing postprandial (after-meal) glucose spikes.\n\nImproves Insulin Sensitivity: Pioglitazone enhances insulin sensitivity in muscle and fat tissues, allowing for better glucose uptake and utilization by cells. This action helps reduce insulin resistance, a hallmark of type 2 diabetes.\n\nReduces Hepatic Glucose Production: Metformin HCI (SR) reduces the production of glucose in the liver, helping to lower fasting blood sugar levels and prevent excessive glucose release into the bloodstream.\n\nExtended Blood Sugar Control: The sustained-release formulations of Gliclazide and Metformin ensure a gradual and prolonged release of the medications, leading to consistent blood sugar control and minimizing the risk of hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) fluctuations.\n\nDosage and Administration:\nTRIGLICLAGLAZE 30 is typically taken orally once or twice daily, as prescribed by a healthcare provider.\nThe medication is often taken with meals to reduce the risk of gastrointestinal side effects.\nDosage adjustments may be necessary based on blood sugar levels and individual response to treatment. Follow your doctor's instructions carefully.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/trigliclaglaze-30-134278", "price": 125.0, "discountamount": 37.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "risk", "drugs", "meals", "Order", "liver", "cells", "EMAIL", "doctor", "muscle", "action", "pancreas", "hallmark", "treatment", "Gliclazide", "fat tissues", "information", "medications", "bloodstream", "Pioglitazone", "sterisonline", "postprandial", "hypoglycemia", "fluctuations", "instructions", "sterispharma", "Key Benefits", "hyperglycemia", "CALL/WHATSAPP", "Metformin HCL", "Metformin HCI", "glucose uptake", "Administration", "TRIGLICLAGLAZE", "low blood sugar", "gradual release", "Insulin Release", "high blood sugar", "prolonged release", "insulin secretion", "different aspects", "multiple pathways", "peripheral tissues", "insulin resistance", "Dosage adjustments", "blood sugar levels", "glucose metabolism", "glucose regulation", "glucose utilization", "individual response", "insulin sensitivity", "healthcare provider", "meal) glucose spikes", "three key components", "biguanide medication", "combination medication", "comprehensive approach", "thiazolidinedione class", "sulfonylurea medication", "type 2 diabetes mellitus", "excessive glucose release", "Hepatic Glucose Production", "overall blood sugar control", "optimal blood sugar control", "extended blood sugar control", "gastrointestinal side effects", "sustained-release formulation", "Comprehensive Glucose Control", "consistent blood sugar control", "sustained-release (SR) formulation", "consistent glucose-lowering effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1484, "imageuri": "https://productimages.withfloats.com/actual/6661af49f21358d53af3ccec.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661af49f21358d53af3ccec.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:44:53.071Z", "updatedon": "2024-06-28T12:15:14.626Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trigliclaglaze-30-/1484", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIGLICLAGLAZE 30 ", "category": "DIABETIC RANGE", "tags": [ "TRIGLICLAGLAZE 30", "Gliclazide (SR)", "Pioglitazone", "Metformin HCL (SR)", "Metformin SR 500mg uses", "Metformin hydrochloride 500 mg", "Metformin SR 500 side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }